Vietnam Osteoporosis Workshop, HCM Cty 2006 Secondary Osteoporosis Tuan Van Nguyen and Nguyen Dinh Nguyen Bone and Mineral Research Program Garvan Institute.

Slides:



Advertisements
Similar presentations
Osteoporosis in IBD. General Risk Factors for Osteoporosis Advancing age Advancing age Female gender Female gender Family history Family history Alcohol.
Advertisements

Osteoporosis 9 th January 2013 Dr Julian Tomkinson.
OSTEOPOROSIS An overview of the condition and its treatment
Update on Osteoporosis Dr Terence O’Neill Consultant Rheumatologist.
Osteoporosis Part 1 of 3: Risk Factors Ellen Davis-Hall, PhD, PA-C Professor Clare J. Kennedy, MPAS, PA-C Assistant Professor, PA Program SAHP, COM UNMC.
WHO Osteoporosis Definition (1996)
Importance of calcium: Ca ++ regulates: Neural function Muscle contraction Secretion of some hormones Blood clotting.
Vietnam Osteoporosis Workshop, HCMC 2006 RISK FACTORS FOR OSTEOPOROTIC FRACTURE IN THE ELDERLY Tuan Van Nguyen and Nguyen Dinh Nguyen Garvan Institute.
Dr santosh kumar Assistant professor Medical unit 2.
Osteoporosis Lucy Cowdrey 4 th November What is it?
Osteoporosis Dr. Lauren Phillips Sugar Land Women’s Health.
Osteoporosis UBC Internal Medicine Program Dr. Mark Fok Dr. Maria Ashley.
Bone Mineral Density Testing March 29, Introduction Osteoporosis is a systemic skeletal disorder characterized by decreased bone mass and deterioration.
UNDERSTANDING OSTEOPOROSIS Stephen L. Kates, MD Hansj ӧ rg Wyss Professor of Orthopaedic Surgery Department of Orthopedics and Rehabilitation Associate.
Osteoporosis Osteoporosis is defined as a loss of bone mass or bone mineral density characterized by height reduction, fractures, back/neck pain, and stooped.
OSTEOPOROSIS Prof. Dr. Ülkü Akarırmak. Metabolic Bone Diseases Osteosclerosis Osteolysis Osteoporosis is the most common metabolic bone disease.
Corticosteroid - Induced Osteoporosis Chatlert Pongchaiyakul. MD. Endocrinology Unit, Medicine Department Faculty of Medicine, Khon Kaen University.
OSTEOPOROSIS 06/25/12 José L. González, PGY3. Definition  Reduction in bone strength  increase risk of fx  T-score: < -2.5 SDs  T-score: 30 yo, matched.
Vietnam Osteoporosis Workshop, HCMC 2006 Assessment of Vertebral Fracture Tuan Van Nguyen and Nguyen Dinh Nguyen Bone and Mineral Research Program Garvan.
Beyond 5 years Francis F. Lopez, MD Medical Oncology.
Osteoporosis and Fractures Are Common, and Becoming More So
The Effect of Zoledronic Acid (ZOL) on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole:
Quiz of the week. 23 years old male patent who presented with sudden onset of sever back pain and his MRI of spine shows a fracture. How do you approach.
Selecting Candidates for Fracture Prevention Based on Risk Prediction Lubna Pal, MBBS, MRCOG, MS Assistant Professor Department of Obstetrics, Gynecology.
Lifetime Veganism: Osteoporosis and Vertebral fracture 1 Thuc Lan Ho-Pham, 2 Nguyen ND, 3 Thu A. Le, 2 Tuan V. Nguyen *Coauthors:, 1 Vu BQ, 3 Pham NH,
Management of men and women over 50yrs who have sustained a fragility fracture: 2011 draft guidance Fragility fracture definition: Fracture site excluding.
Hanna Przepiera-Będzak Klinika Reumatologii PAM, Szczecin.
Interpretation of Bone mineral density
Osteoporosis Dr. Faik Altıntaş Yeditepe Üniversitesi Tıp Fakültesi
Osteoporosis Management: Clinical scenario
Glucocorticoid-Induced Osteoporosis (GIO) Nguyen Thy Khue, MD, PhD Department of Endocrinology, HoChiMinh City University of Medicine and Pharmacy.
Presenting … Nutrition and Osteoporosis “I’ve lost six inches in height and none of my clothes fit me anymore. Plus, it’s hard to get clothes that look.
By Siraya Kitiyodom ปัญหาที่เกี่ยวกับสุขภาพ ที่พบบ่อยในสตรีวัยทอง และวิธีการดูแล (Part II)
MANAGEMENT OF OSTEOPOROSIS Professor Opinder Sahota Consultant Physician QMC, Nottingham.
Vietnam Osteoporosis Workshop, HCM Cty 2006 OSTEOPOROSIS IN MEN Tuan Van Nguyen and Nguyen Dinh Nguyen Garvan Institute of Medical Research Sydney, Australia.
Fracture risk assessment
Osteoporosis. What is Osteoporosis? A person with osteoporosis has lost a significant amount of bone mass and is subsequently at increased risk for fracture.
A Look at Osteoporosis Screening Guidelines Cynthia Phelan PGY
Parathyroid disorders
Osteoporosis Armed Forces Academy of Medical Sciences.
CHOICE OF TREATMENTS OF OSTEOPOROSIS IN VIETNAM Le Anh Thu, MD, PhD Department of Rheumatology Cho Ray Hospital, Vietnam.
Osteoporosis. Background ► The problem  Osteoporosis is common  Over 50% of women and 30-45% of men over age 50 have osteopenia/osteoporosis  White.
Osteoporosis: Measuring the Problem
Alimohammad Fatemi Assistant Professor of Rheumatology 1.
Vitamin D, Rickets and Osteoporosis
Metabolic Diseases of the Bone
Osteoporosis By: Renee Alta. Pathophysiology/Etiology Characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility.
Osteoporosis In Thalassemia Dr Tarek Jawad INT 555.
Welcome To Our Presentation
OSTEOPOROSIS. Characteristics of osteoporosis include a reduction of bone density and a change in bone structure, both of which increase susceptibility.
Chapter 47 Assessing Fracture Risk: Who Should Be Screened? © American Society for Bone and Mineral Research Contributed by John Schousboe, Brent Taylor,
Osteopenia and Osteoporosis Bradley K. Harrison, MD.
NICE, FRAX & NOGG VTS meeting Jonathan Day 7 th April 2010.
Chapter 48 Evaluation of Postmenopausal Osteoporosis © American Society for Bone and Mineral Research Contributed by Susan Greenspan and Marjorie Luckey.
Osteopenia and Osteoporosis
Osteoporosis Vinod Kurup, MD December 22nd, 2006 CC-BY-SA.
Osteoporosis.
Osteoporosis هشاشة العظام Dr.Fakhir Yousif.
Patient 65 years old retired teacher with severe back pain
Post Menopausal Osteoporosis
Osteoporosis Definition
OSTEOPOROSIS. OSTEOPOROSIS Osteoporosis Osteoporosis affects both men and women. Its prevalence increases with age, and it is particularly common in.
Chapter Drugs used for the treatment of osteoporosis
Deciding on Pharmacological Treatment Post Fracture
Deciding on Pharmacological Treatment Post Fracture
Lecture 6 Rheumatologic Disorders Osteoporosis
(Relates to Chapter 64, “Focous on osteoperosis ,” in the textbook)
Osteoporosis: Definition
Presentation transcript:

Vietnam Osteoporosis Workshop, HCM Cty 2006 Secondary Osteoporosis Tuan Van Nguyen and Nguyen Dinh Nguyen Bone and Mineral Research Program Garvan Institute of Medical Reseach Sydney, Australia

Vietnam Osteoporosis Workshop, HCM Cty 2006 Overview Definitions Causes Corticosteroid Induced Osteoporosis: –Machanism –Magnitude of the problem –Patient managements

Vietnam Osteoporosis Workshop, HCM Cty 2006 Secondary osteoporosis Results from chronic conditions that contribute significantly to accelerated bone loss. Treatment of secondary osteoporosis is more complex than that of primary osteoporosis. Prognosis depends on the underlying disease.

Vietnam Osteoporosis Workshop, HCM Cty 2006 Secondary Osteoporosis Endocrine or Metabolic causes Medications Collagen/genetics disorders Nutritional disorders Forms of secondary osteoporosis

Vietnam Osteoporosis Workshop, HCM Cty 2006 Endocrine or metabolic causes Hypogonadism Hyperparathyroidism Cushing-syndrome Acidosis Diabetes (type I) Androgen insensitivity Hemochromatosis Gaucher’s disease

Vietnam Osteoporosis Workshop, HCM Cty 2006 Medications Corticosteroids Thyroid GnRH antagonists Anti-neoplastic agents Cyclosporin, methotrexate Phenobarbital Phenothiazines, Phenytoin

Vietnam Osteoporosis Workshop, HCM Cty 2006 Collagen/genetic disorders Ehler-Danlos syndrome Glycogen storage diseases Homocysturina Hypophosphatasis Marfan syndrome Osteogenesis Imperfecta

Vietnam Osteoporosis Workshop, HCM Cty 2006 Nutritional Alcoholism Calcium deficiency Chronic liver disease Gastric operations Malabsorption syndromes Vitamin D deficiency

Vietnam Osteoporosis Workshop, HCM Cty 2006 Corticosteroid-induced Osteoporosis (CIOP)

Vietnam Osteoporosis Workshop, HCM Cty 2006 Corticosteroid-induced osteoporosis CS used in many underlying diseases Benefits effects on the underlying disease vs. detrimental effects on bone. High percentage of osteoporosis and fracture Dose-dependent effect  difficult to define

Vietnam Osteoporosis Workshop, HCM Cty 2006 CIPO-Epidemiology Prevalence of use of oral corticosteroids: – Population: 0.5% – Among women aged ≥ 55: 1.7% L J Walsh et al, BMJ 1996;313:344-6 Main indications: – Rheumatoid arthritis – Polymyalgia – COPD 14% of patients taking any treatment of osteoporosis

Vietnam Osteoporosis Workshop, HCM Cty 2006 CIPO: Burden Most common of drug-related osteoporosis in men and women Occur at any age, in both sexes, across races Up to 50% patient of chronic steroid therapy sustain osteoporotic fractures and/or develop osteonecrosis. Significant bone loss can occur in as little as 3 months. 50% chance of developing osteoporosis if on steroid for 6 mo.

Vietnam Osteoporosis Workshop, HCM Cty 2006 Corticosteroids-effect on bone Corticosteroids Osteoblast Inhibition enhancement Bone resorption Calcium loss increase Calcium absorption Inhibition Gonadal hormone

Vietnam Osteoporosis Workshop, HCM Cty 2006 Who is at high-risk of CIPO? Eastell R et al, J Intern Med 1998;244: Tobias JH, Rheumatology 1999;38: Prior fracture - Premature menaupause at < 45y - Age > 65 y - Planned or current use CS > 6 mo - Low weight - Other causes of Osteoporosis

Vietnam Osteoporosis Workshop, HCM Cty 2006 CIPO and fracture (Source: van Staa TP et al., 2000)

Vietnam Osteoporosis Workshop, HCM Cty 2006 Patient assessment Eastell R et al, J Intern Med 1998;244: BMD measurement BMD-Tscores? High-risk of CIOP? >1 0 to -1.5 < -1.5 or with CS >15mg/d or with CS 7.5mg/d x 6mo -Thoracic and lumbar spine X-ray -FBC, ESR & S-Electrophoresis if necessary -Serum Ca, P, AP, Albumin -Thyroid function -Men: testosterone an women: FSH, LH In 3-5 y After 1 y Lifestyle modification advice: -Smoking -Alcohol -Physical activity -Prevent fall

Vietnam Osteoporosis Workshop, HCM Cty 2006 CIOP-Management Primary prevention, PP (treatment started at the time initiation up to 3 mo of CS therapy) Secondary prevention, SP (treatment started >1y after the time initiation of CS therapy)

Vietnam Osteoporosis Workshop, HCM Cty 2006 Pharmacological therapy AgentPPSPDose Calcium &Vit Dvv1000mg/d & 50000U/w CalcitrolvNA0.6µg/d AlfacalcidiolvNA1µg/d CalcitoninvNAConflicting results (200U/d, nasal) Fluoridevv25mg BID plus Calcium Etidronatevvmarginal effect Alendronatevv5mg/d PamidronatevvIntermittent IV Risedronatevv5mg/d HRTNAv Testosterone (men)NAv

Vietnam Osteoporosis Workshop, HCM Cty 2006 Key messages Secondary osteoporosis is common Patients on CS therapy should be consider the need for therapy to prevent or treat CIOP Data on CIOP fracture reduction with treatment remain sparse

Vietnam Osteoporosis Workshop, HCM Cty 2006 Lời Cảm tạ Chúng tôi xin chân thành cám ơn Công ty Dược phẩm Bridge Healthcare, Australia là nhà tài trợ cho hội thảo.

Vietnam Osteoporosis Workshop, HCM Cty 2006 Thank you!